Pharmaceutical companies pay Hawaii $ 700 million to settle the Plavix Blood Min Plus trial
Honolulu – Pharmaceutical companies have agreed to pay Hawaii $ 700 million to set up its trial for the thinner Plavix and Safety, the Office of the State Attorney General said on Friday.
Last year, a court decision ordered Bristol Myers Squibb Company and three US subsidiaries of the French Pharmaceutical Sanofi to pay 916 million dollars combined.
But before a call was decided, a settlement was concluded for the lower amount, said the prosecutor’s office.
In a joint statement, companies said they “were happy to resolve this dispute and continue to focus on the discovery, development and supply of innovative drugs to patients”.
“Plavix has helped millions of people with cardiovascular disease worldwide for almost 30 years and it continues to be approved as first -line therapy by directing processing directives around the world,” the statement added.
The circuit judge James Ashford concluded that there was a risk that around 30% of patients, especially non-Caucasians, have a “reduced response” in Plavix, but companies have not updated their labels, the general prosecutor Anne Lopez said last year.
None of the two companies recognized the reprehensible acts.
Governor Josh Green described it as “historic regulations” and “major victory” for the State.
The regulations also divide the $ 700 million between Bristol Myers Squibb and Sanofi, the funds which will be paid by bank transfer before June 9, said the prosecutor’s office.
